Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.50 | N/A |
| PEG Ratio (TTM) | 18.75 | N/A |
| P/S Ratio (TTM) | 3.27 | N/A |
| P/B Ratio (TTM) | 2.75 | N/A |
| P/FCF Ratio (TTM) | 17.89 | N/A |
| Price to 5YR AVG Earnings Ratio | 30.92 | N/A |
| Price to 5YR AVG FCF Ratio | 17.27 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.83% | N/A |
| ROE (TTM) | 10.87% | N/A |
| Net Profit Margin (TTM) | 12.26% | N/A |
| ROIC 5YR AVG | 8.87% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.43% | 120.83% | 68.00% |
| Revenue | 1.79% | 14.80% | 10.63% |
| Net Income | 3.21% | 131.81% | 74.02% |
| Cash Flow | 28.92% | 39.11% | 20.77% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.21 | N/A |
| Quick Ratio (TTM) | 1.21 | N/A |
| D/E Ratio (TTM) | 1.06 | N/A |
| Interest Coverage (TTM) | 2.93 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.85 | N/A |
| LTL to 5YR AVG FCF | 6.29 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.40% | N/A |